The formation of new infectious human immunodeficiency type 1 virus (HIV-1) mainly relies on the homo-multimerization of the viral structural polyprotein Pr55 Gag and on the recruitment of host factors. We have previously shown that the double-stranded RNA-binding protein Staufen 1 (Stau1), likely through an interaction between its third double-stranded RNAbinding domain (dsRBD3) and the nucleocapsid (NC) domain of Pr55 Gag , participates in HIV-1 assembly by influencing Pr55 Gag multimerization.
Background
Human immunodeficiency type 1 (HIV-1) assembly consists in the formation of new viral particles which is the result of the radial multimerization of approximately 1,400 to 5,000 copies of the viral polyprotein Pr55 Gag (also named Gag) according to their quantification in mature or immature particles, respectively [1] [2] [3] . Pr55 Gag is thought to contain most of the determinants required for viral assembly since the expression of Pr55 Gag alone leads to the formation and release of virus-like particles (VLPs), structurally not really distinguishable from immature HIV-1 [4] [5] [6] . Pr55 Gag is a modular protein that contains 6 domains: matrix (MA), capsid (CA), nucleocapsid (NC), p6 and two spacer peptides, p2 and p1. Each of these domains plays specific roles during HIV-1 life cycle. During assembly, the MA domain, through its myristylated moiety and its highly basic domain, anchors assembly complexes to membranes [4] [5] [6] . Whether assembly takes place at the inner leaflet of the plasma membrane or at the multivesicular bodies (or both) is still under debate [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .
Pr55 Gag multimerization is likely initiated by NC/NC contacts [18, 19] probably when Pr55 Gag is still in a cytosolic compartment [20] [21] [22] [23] . The basic amino acid stretch present in NC is thought to non-specifically recruit RNA that serves as a scaffold for multimerizing Pr55 Gag [24] [25] [26] . Indeed, mutations abrogating the global positive charge of this sub-domain compromise viral assembly [24, 25] . NC also possesses two zinc fingers that are important for the specific packaging of HIV-1 genomic RNA [27] [28] [29] . Recently, Grigorov et al. demonstrated the involvement of both NC zinc fingers in Pr55 Gag cellular localization and HIV-1 assembly [30] . Similarly, the first NC zinc finger was shown to be part of the minimal Pr55 Gag sequence required for multimerization (called the I domain) [5, 6] . Since NC function during assembly can be mimicked by its substitution with a heterologous oligomerization domain [31, 32] , NC/NC contacts probably serve as a signal for the higher order multimerization of Pr55 Gag under the control of other domains. Indeed, the C-terminal third of the CA domain and the spacer peptide p2 are part of the I domain and have been shown by mutagenesis and structural analyses to be also very important players during HIV-1 assembly [26, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] .
The HIV-1 assembly process within the cell appears to be tightly regulated in time and space and relies on the sequential acquisition and release of host proteins that are required for the cellular localization, multimerization and budding of new capsids [4, 43] . For instance, the ATPbinding protein ABCE1/HP68 is important for the completion of Pr55 Gag multimerization via a transient interaction with the NC domain of Pr55 Gag [44] [45] [46] [47] . Adaptor proteins 1, 2, 3 (AP-1; AP-2; AP-3) are involved in Pr55 Gag intracellular trafficking through their association with the MA domain of Pr55 Gag [12, 48, 49] . Finally, endosomal sorting complex required for transport (ESCRT)-I and -III machineries are recruited by the p6 domain of Pr55 Gag and are crucial for the budding and release of the neosynthesized viral particles [50] . Staufen1 (Stau1) is also a Pr55 Gag -binding protein that influences HIV-1 assembly [51] [52] [53] . Stau1 belongs to the double-stranded RNA-binding protein family [54, 55] and is involved in various cellular processes related to RNA. Stau1 was first studied for its role in the transport and localization of mRNAs in dendrites of neurons [56] . More recently, Stau1 was identified as a central component of a new mRNA decay mechanism termed Staufen-mediated decay [57] . In addition to its functions in RNA localization and decay, Stau1 can also stimulate translation of repressed messengers containing structured RNA elements in their 5'UTR [58] .
Stau1 is a host factor that is selectively encapsidated into HIV-1 [53] . Stau1 co-purifies with HIV-1 genomic RNA and interacts with the NC domain of Pr55 Gag [52, 53] suggesting that Stau1 assists NC's functions during the HIV-1 replication cycle. Stau1 levels in the producer cells are important for HIV-1 since both Stau1 overexpression and depletion using RNA interference affect HIV-1 infectivity [52, 53] . In addition to a putative role in HIV-1 genomic RNA packaging [53] , we recently showed that Stau1 modulates HIV-1 assembly by influencing Pr55 Gag multimerization [51] . Indeed, using a new Pr55 Gag multimerization assay relying on bioluminescence resonance energy transfer (BRET), we demonstrated that both Stau1 overexpression and depletion enhanced multimerization and consequently increased VLP production. Although Stau1 and Pr55 Gag interact in both cytosolic and membrane compartments, this effect of Stau1 on Pr55 Gag oligomerization was only observed in membranes, a cellular compartment in which Pr55 Gag assembly primarily occurs. However, the mechanism by which Stau1 influences HIV-1 assembly at the molecular level remains unknown although it is likely that it relies on the Stau1 interaction with HIV-1 Pr55 Gag .
Using co-immunoprecipitation and BRET assays, we showed that both Pr55 Gag NC zinc fingers are involved in Stau1/Pr55 Gag interaction as does the Stau1 dsRBD3 [52] . Unexpectedly, we found that the binding of Stau1 to NC is not sufficient per se to fully enhance Pr55 Gag multimerization. To determine which domain of Stau1 modulates the HIV-1 Pr55 Gag multimerization process, we analyzed several Stau1 deletion mutants for their capacity to enhance Pr55 Gag multimerization. Using the Pr55 Gag / Pr55 Gag BRET assay either in live cells or after cell fractionation, we showed that the first 88 amino acids at the Nterminal of Stau1 confer the capacity to enhance both Pr55 Gag multimerization and VLP production. Although unable to enhance multimerization, this mutant was still able to interact with Pr55 Gag . This study provides important new information about the molecular determinants required for Stau1 function in HIV-1 assembly.
Methods

Cell culture and reagents
Human embryonic kidney fibroblasts (HEK 293T) were cultured in Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with 10% cosmic calf serum (HyClone) and 1% penicillin/streptomycin antibiotics (Multicell). Transfections were carried out using either the calcium phosphate precipitation method or the Lipofectamine 2000 reagent (Invitrogen). For Western blots, mouse and rabbit HRP-coupled secondary antibodies were purchased from Dako Cytomation and signals were detected using the Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life Sciences). Signals were detected with a Fluor-S MultiImager apparatus (Bio-Rad). Anti-Na-K ATPase antibodies were kindly provided by Dr. Michel Bouvier.
Plasmid construction
The construction of pcDNA3-RSV-Stau1 55 
pCMV-Stau1 ΔdsRBD3 -YFP, pCMV-Pr55 Gag -Rluc, pCMV-Pr55 Gag -YFP, pCMV-NC-p1-YFP and pCMV-CA-p2-NC-p1-Rluc was reported before [51] [52] [53] [54] 59] . The HxBRU PR-provirus and the Rev-independent Pr55 Gag expressor were described before [51, 53, 60] .
To construct pcDNA-RSV-Stau1 ΔNt37 -HA 3 , a polymerase chain reaction (PCR) was performed using pcDNA3-RSV-Stau1 55 -HA 3 as template, sense (5'-ATCAGGTACCAT-GGGTCCATTTCCAGTTCCACCTTT-3') and anti-sense (5'-CACATCTAGATCATTTATTCAGCGGCCGCACTGAG-CAGCGT-3') oligonucleotide primers and the Phusion DNA polymerase (New England Biolabs). The PCR product was purified and digested with KpnI and XbaI restriction enzymes (Fermentas) and then cloned into the KpnI/ XbaI cassette of pCDNA3-RSV.
To generate pcDNA-RSV-Stau1 55 -Flag plasmid, oligonucleotides (5'-GGCCTTGATTACAAGGATGACGAT-GACAAG-3' and 5'-GGCCCTTGTCATCGTCATCCTTGTAATCAA-3') were hybridized and then inserted into the NotI sites of pcDNA-RSV-Stau1 55 -HA 3 in replacement of the HA-tag. For the construction of pcDNA-RSV-Stau1 ΔNt88 -Flag, the EcoRI fragment of pcDNA-RSV-Stau1 ΔNt88 -HA 3 that contained the mutated Stau1 sequence, was cloned into EcoRIdigested pcDNA-RSV-Stau1 55 -Flag plasmid.
The expressors of NC-p1-YFP and Pr55 Gag -YFP mutants were PCR amplified using the PCR all-around technique [59] to generate the following mutations: the C15S mutation was introduced with the primer pair 5'-AAGAGTT-TCAATTGTGGCAAA-3' and 5'-GAAACTCTTAACAATCTTTCT-3'; the C49S mutation was generated with the primer pair 5'-GATAGTACTGAGA-GACAGGCT-3' and 5'-AGTACTATCTTTCATTTGGTG-3'; R7S, R10S and K11S mutations (R7 mutant) were introduced with the primer pair 5'-TTTAGCAACCAAAGCTC-GATTGTTAAGTGTTTC-3' and 5'-AATCGAGCTTTGGTTGCTAAAATTGCCTCTCTG-3'. PCR reactions were carried out with the Phusion enzyme (New England Biolabs) at 95°C for 50 s, 55°C for 60 s and 72°C for 90 s, for 18 cycles. Resulting products were incubated with 10 units of DpnI enzyme (Fermentas) and then transformed into competent bacteria. Positive clones containing the mutation(s) were screened by restriction and sequencing analyses. The double zinc fingers mutant expressors (pCMV-Pr55 Gag C15-49S -YFP and pCMV-NC-p1 C15-49S -YFP) were generated by PCR with the oligonucleotide primer pair for the C49S mutation using the corresponding plasmids that contain the C15S mutation.
Membrane flotation assays and S100-P100 fractionation
Forty hours post-transfection, cell extracts were prepared by passing the cells 20 times through a 23G1 syringe in TE (10 mM Tris pH7.4, 1 mM EDTA pH 8) containing 10% sucrose and proteases inhibitors (Roche). Nuclei were removed by centrifugation at 1,000 × g. Resulting cytoplasmic extracts were separated using the membrane flotation assay as previously described [51] . Membraneassociated complexes were collected (fractions 2 and 3). Membranes were solubilized by treating these complexes with 0.5% Triton X-100 at room temperature for 5 minutes and samples were subjected to S100/P100 fractionation as previously described [51] by ultracentrifugation at 100,000 × g for 1 h at 4°C. Supernatants (S100 fractions) and pellets (P100 fractions) were collected and analyzed by Western blotting using anti-CA, anti-HA and anti-Na-K ATPase mouse antibodies.
BRET assays
293T cells were transfected in 6-well plates with constant amounts of the Rluc-fused energy donor expressor (25-75 ng), increasing amounts of YFP-fused acceptor expressor (0.25-2 μg) and Stau1-HA 3 -expressing plasmid (1-1.5 μg) when indicated. 48 hours post-transfection, cells were collected in PBS-EDTA 5 mM and diluted to approximately 2 × 10 6 cells/mL. BRET assays were performed as described before [51, 52] using a Fusion α-FP apparatus (Perkin-Elmer). In this interaction assay, an X-Rluc fusion protein is used as an energy donour whereas a Y-YFP fusion protein is an energy acceptor. When the two fusion proteins are in close proximity (< 100Å), non-radiative resonance energy is transferred from X-Rluc to Y-YFP which in turn emits measurable fluorescence. This can be quantified by the calculation of the BRET ratio which allows detection of protein-protein interactions. The BRET ratio was defined as [(emission at 510 to 590 nm)-(emission at 440 to 500 nm) × Cf]/(emission at 440 to 500 nm), where Cf corresponds to (emission at 510 to 590 nm)/(emission at 440 to 500 nm) when Rluc fused protein is expressed alone. The total YFP activity/Rluc activity ratio reflects the relative levels of the two fusion proteins in the cells. The BRET ratio increases with the total YFP activity/Rluc activity ratio since more YFP-fused molecules bind to Rluc-fused proteins. For Pr55 Gag multimerization assays, in order to avoid misinterpretation due to variations in relative levels of the Pr55 Gag fusion proteins, changes in the Pr55 Gag /Pr55 Gag BRET ratios following Stau1 overexpression were always analyzed at similar total YFP activity/Rluc activity ratio.
When Pr55 Gag /Pr55 Gag BRET assays were performed following membrane flotation assays, the Rluc substrate coelenterazine H (NanoLight Technology) was added to 90 μL of each fraction and BRET ratio was determined as in live cells. BRET ratios in fractions 1, 3, 4, 5 and 6 were not considered because luciferase activity was too low in these fractions and hence, did not lead to the determination of a reliable BRET ratio.
For CA-p2-NC-p1-Rluc/Stau1-YFP and Stau1 55 -Rluc/NC-p1-YFP interaction assays, BRET ratios were always compared at similar total YFP activity/Rluc activity ratio. The BRET ratio determined in the context of the expression of the unfused YFP protein (YFP) corresponds to non specific interactions between the energy donor and the YFP. Hence, this background BRET ratio was always subtracted from all BRET ratios and was set to 0%. The BRET ratio determined following co-expression of the energy donor and the wild type energy acceptor was set to 100%.
For dose-response Pr55 Gag /Pr55 Gag BRET assays, 293T cells were transfected with fixed amounts of pCMV-Pr55 Gag -Rluc and pCMV-Pr55 Gag -YFP and increasing amounts (0.25-2 μg) of different Stau1-HA 3 expressors. BRET assays were performed 48 hours post-transfection as described above.
Co-immunoprecipitation assays
293T cells were transfected with Stau1 55 -flag and Gag expressors using Lipofectamine 2000 (Invitrogen). Twenty hours post-transfection, cells were collected in lysis buffer (150 mM NaCl, 50 mM Tris pH 7.4, 1 mM EDTA, 1% Triton X-100) containing proteases inhibitors (Roche). Each cell lysate (1.5 mg of proteins) was precleared with IgG-agarose (Sigma-Aldrich) for 1 h at 4°C and then subjected to immunoprecipitation using 15 μL of anti-Flag M2 affinity gel (Sigma-Aldrich) for 2 h at 4°C. Immune complexes were washed 3 times during 5 minutes with cold lysis buffer, eluted with the Flag peptide (Sigma-Aldrich), resolved in SDS-containing acrylamide gels and analyzed for their content in Stau1 and Gag proteins by Western blotting using mouse monoclonal anti-Flag (Sigma-Aldrich), anti-GFP (Roche) and anti-CA antibodies.
Virus-like particle purification
293T cells were transfected with Stau1 55 -HA 3 and Gag expressors using Lipofectamine 2000 (Invitrogen). Twenty hours post-transfection, supernatants were collected and cleared through a 0.45 μm filter. VLPs were pelleted through a sucrose cushion (20% in Tris-NaCl buffer) by ultracentrifugation during 1 hour at 220,000 × g. VLPs were resuspended in Tris-NaCl buffer and analyzed by Western blotting using anti-CA antibodies. Pr55 Gag signals in the VLPs and the cell extracts were quantitated using the Quantity One (version 4.5) software (Bio-Rad).
Results
Both NC zinc fingers mediate Stau1/Pr55 Gag interaction
The interaction between Stau1 and Pr55 Gag is likely a critical determinant for Stau1 function in HIV-1 assembly. Indeed we previously showed that a single point mutation in the third double-stranded RNA-binding domain of Stau1 (Stau1 F135A ) prevented both the association of the mutant to Pr55 Gag and the Stau1-mediated increase of HIV-1 assembly [51] [52] [53] . Moreover, we showed that Stau1/Pr55 Gag interaction required the NC domain [52] that contains motifs involved in several steps during HIV-1 assembly. As a first step, to understand the molecular mechanisms underlying Stau1 influence on HIV-1 assembly, we identified which NC sub-domain is required for Pr55 Gag /Stau1 association using the BRET assay with Stau1 55 -Rluc and wild type or mutant NC-p1-YFP fusion proteins. Four NC mutants were constructed. Point mutations were introduced in the NC-p1-YFP fusion protein to disrupt the first zinc finger (NC-p1 C15S -YFP), the second (NC-p1 C49S -YFP), both zinc fingers (NCp1-YFP C15-49S ) or the N-terminal basic residues (NCp1-YFP R7 )( Figure 1A ). For this mutant, Arg 7 , Arg 10 and Lys 11 were substituted for serines ( Figure 1A ). Mutations in this basic region were previously reported to severely affect HIV-1 assembly [24] . Constructs encoding the wild type and mutants NC fusion proteins were transfected in 293T cells and their expression patterns were analyzed by Western blotting using an anti-GFP antibody. Figure 1B shows that wild type and mutant NC-p1-YFP proteins were well expressed and have the expected molecular weight. However, for unknown reasons, NC-p1 C15-49S -YFP was always slightly less expressed than the other NC-p1-YFP proteins.
These proteins were then tested for their capacity to interact with Stau1 55 using the BRET assay in live 293T cells ( Figure 2A ). This technique allows us to detect proteinprotein interaction in live cells between Rluc-fused Stau1 and NC-p1-YFP molecules (Figure 2A ). Indeed, when the two fusion proteins are in close proximity (≤ 100Å) as a consequence of Stau1-NC interaction, non-radiative reso- Mock
Design and expression of NC mutants used for the fine mapping of Stau1/NC interaction
The NC zinc fingers mediate Stau1/Pr55 Gag interaction 
-YFP YFP nance energy is transferred from the emitting Rluc to YFP which becomes excited and in turn emits fluorescence. A BRET ratio is calculated for each condition (see Methods). To perform BRET saturation experiments, we transfected 293T cells with constant amounts of pCMV-Stau1 55 -Rluc plasmid and increasing amount of different NC-p1-YFP expressors. BRET assays were performed 48 hours posttransfection (Figures 2A, B ). BRET saturation experiments allowed us to compare BRET ratios at the same relative ratio between fusion proteins (comparable total YFP/Rluc ratio) ( Figure 2B ). As expected, we readily detected a specific BRET between wild type NC-p1-YFP and Stau1 55 -Rluc (arbitrarily set to 100% in Figure 2B ) as compared to coexpression of Stau1 55 -Rluc and YFP alone (Figures 2A, B) . Mutations that modify the NC N-terminal basic region did not affect the binding of NC to Stau1 since the saturation profile for Stau1/NC-p1 R7 -YFP BRET was almost identical to the one obtained with Stau1/NC-p1-YFP ( Figures 2A, B) . In contrast, when the two zinc fingers were mutated (NC-p1 C15-49S -YFP), the BRET saturation profile was comparable to that obtained with YFP alone and hence, mostly attributable to background (Figure 2A) . When compared to NC-p1-YFP at the same total YFP/Rluc ratio, the corrected BRET ratio was decreased by 80% (Figure 2B ). This suggests that NC-p1 C15-49S -YFP lost almost completely its ability to interact with Stau1. Mutations in individual zinc finger (NC-p1 C15S -YFP and NC-p1 C49S -YFP) only affected the BRET ratio by 30-40% and these two mutants showed an intermediate profile (Figures 2A,  B ).
This suggests that the integrity of at least one NC zinc fingers is required for Stau1/NC interaction.
We used a second technique to confirm the involvement of both zinc fingers in Stau1-NC interaction in the context of full-length Pr55 Gag . We generated a Pr55 Gag -YFPexpressing plasmid in which both zinc fingers were mutated (Pr55 Gag C15-49S -YFP)(see below). As shown in Figure 2C , this mutant was expressed to the same level as the wild-type Pr55 Gag -YFP and migrated in SDS-containing acrylamide gels at the expected molecular weight (80 kDa). Following co-expression of Flag-tagged Stau1 55 with wild type or mutated Pr55 Gag -YFP in 293T cells ( Figure  2D impaired. Pr55 Gag C15S -YFP and Pr55 Gag C49S -YFP mutants retained some association with Stau1 55 -Flag although they displayed lower binding capability than the wild type Pr55 Gag (not shown), consistent with the BRET assay. Altogether, these results show that the two zinc fingers within the NC domain of Pr55 Gag mediate its association with Stau1. Moreover, this suggests that Stau1 influences those assembly processes that depend on NC zinc fingers.
Mutations in the NC zinc fingers severely compromises Pr55 Gag multimerization and release
The fact that Stau1 influences HIV-1 Pr55 Gag multimerization and associates with NC zinc fingers is consistent with previous reports showing that these structural motifs are important in HIV-1 assembly [29, 30, 46] . To confirm this hypothesis in a system that tests direct interaction, we evaluated the consequence of mutations in the Pr55 Gag zinc fingers on VLP release and on Pr55 Gag dimerization using the BRET assay. 293T cells were transfected with Pr55 Gag -YFP and Pr55 Gag C15-49S -YFP expressors ( Figure  3A ). Twenty-four hours post-transfection, VLPs were collected from the supernatant and cells were collected. In the cell extracts, Pr55 Gag -YFP and Pr55 Gag C15-49S -YFP were present at similar levels ( Figure 3B , left panel). In contrast, the release of Pr55 Gag C15-49S -YFP in the cell supernatant was reduced by 95.1% (+/-3.4 S.D.; n = 3) as compared to that of Pr55 Gag -YFP ( Figure 3B , right panel) suggesting that this mutant failed to efficiently assemble. Used as a negative control, MA-CA WM184-185AA -YFP ( Figure 3A) , a Pr55 Gag mutant that was shown to be almost completely monomeric in the cell and unable to generate VLPs [26, 51] , was not detected in the cell supernatant although it was expressed at higher levels than Pr55 Gag -YFP and Pr55 Gag C15-49S -YFP in the cell ( Figure 3B ).
Then, we determined whether mutations in the zinc fingers affect Pr55 Gag multimerization. Using the BRET assay in live cells, we tested the capacity of Pr55 Gag C15-49S -YFP to dimerize with Pr55 Gag -Rluc, the wild-type Pr55 Gag -YFP being used as control ( Figure 3A ). As shown in Figure 3C , Pr55 Gag homo-dimerization was readily detectable with a BRET ratio of 0.09 at saturation. In contrast, Pr55 Gag C15-49S -YFP failed to interact with Pr55 Gag -Rluc in the BRET assay since its saturation curve was similar to the one obtained with the monomeric Gag mutant MA-CA WM184-185AA -YFP. Altogether, these results clearly show that, in the context of VLP assembly, Pr55 Gag zinc fingers are important for multimerization and release. This suggests that Stau1, through its binding to the NC zinc fingers could influence crucial processes that are controlled by these motifs during HIV-1 assembly. 
Disruption of both Pr55 Gag zinc fingers affects VLP production
The N-terminal domain of Stau1 is required for the Stau1mediated enhancement of Pr55 Gag multimerization
We previously showed that Stau1 over-expression or depletion from cells enhanced Pr55 Gag multimerization.
To determine if the binding of Stau1 to NC is sufficient for Pr55 Gag multimerization or whether other determinants within Stau1 are required for this process, we tested several Stau1 deletion mutants for their capacity to enhance assembly ( Figure 4A ). To this end, we used the previously described Pr55 Gag /Pr55 Gag BRET assay in live 293T cells as a sensor for changes in Pr55 Gag multimerization ( Figure  4B ) [51] . Indeed, Rluc-and YFP-fused Pr55 Gag co-expression generates a positive BRET ratio in live cells as a consequence of Pr55 Gag multimerization. In order to compare BRET ratio changes at the same relative levels of Pr55 Gag fusion proteins, we performed BRET saturation experiments. As previously reported, when Stau1 55 -HA 3 was coexpressed with Pr55 Gag -Rluc and Pr55 Gag -YFP in 293T cells, the Pr55 Gag /Pr55 Gag BRET ratio increased as a consequence of enhanced Pr55 Gag multimerization (Figures 4B) [51] . Several HA-tagged Stau1 deletion mutants were then tested for their capacity to enhance Pr55 Gag /Pr55 Gag BRET ratio and hence, Pr55 Gag multimerization. Interestingly, Stau1 ΔNt88 -HA 3 , a mutant that lacks the dsRBD2 as a consequence of the deletion of the first N-terminal 88 amino acids ( Figure 4A ) was unable to significantly increase the Pr55 Gag /Pr55 Gag Figures 4B, D) . Western blot analyses showed that Stau1 ΔNt88 was expressed at levels comparable to that of wild type Stau1-HA 3 ( Figure 4C ). Nevertheless, a moderate increase in Pr55 Gag multimerization was seen when Stau1 ΔNt88 was highly over-expressed although its effect on Pr55 Gag multimerization was always weaker than that obtained with Stau1 55 -HA 3 (see below). In contrast, mutants with deletion in dsRBD4, dsRBD5 or tubulinbinding domain (TBD) all enhanced the Pr55 Gag /Pr55 Gag BRET ratio at levels comparable to that obtained with Stau1 55 -HA 3 (data not shown). As control, Stau1 F135A -HA 3 , a Stau1 mutant that does not bind Pr55 Gag , failed to stimulate Pr55 Gag multimerization (data not shown) [51] . Therefore, the Stau1-mediated enhancement of Pr55 Gag multimerization requires two determinants: dsRBD3 for the association with NC and the N-terminus.
Stau1 ΔNt88 still interacts with HIV-1 Gag
To test the ability of Stau1 ΔNt88 to interact with Pr55 Gag , we performed BRET assays between Stau1 ΔNt88 -YFP and a truncated Pr55 Gag (CA-p2-NC-p1-Rluc) that was previously shown by the co-immunoprecipitaton assay to interact as efficiently with Stau1 as full-length Pr55 Gag [52] and ( Figure 5A ). To verify efficiency between these molecules, Stau1 ΔNt88 -YFP and Stau1 55 -YFP were expressed ( Figure 5B ) and the BRET saturation profiles determined ( Figure 5C ). Curves obtained with Stau1 55 -YFP and with Stau1 ΔNt88 -YFP were almost similar suggesting that Stau1 ΔNt88 mutant retains its capacity to bind to Pr55 Gag . The BRET ratios were specific since the Gag-binding deficient mutant Stau1 ΔdsRBD3 -YFP showed reduced BRET ratios. In independent saturation experiments ( Figure  5D ), the specific BRET ratio following co-expression of Stau1 ΔNt88 -YFP and CA-p2-NC-p1-Rluc was comparable [105.7 (+/-18.1 S.D.)% of CA-p2-NC-p1/Stau1 55 corrected BRET ratio] to that obtained with wild type Stau1 55 -YFP at similar total YFP/Rluc ratio. We could not detect a specific BRET signal when Stau1 F135A -YFP [52] was used The ability of Stau1 ΔNt88 to associate with Pr55 Gag was confirmed in co-immunoprecipitation assays ( Figure 5E ). Pr55 Gag and flag-tagged Stau1 or Stau1 ΔNt88 were coexpressed in 293T cells ( Figure 5E , left panel) and proteins in the cell extracts were immunoprecipitated using antiflag antibody. Western blot analyses of the immune complexes showed that Pr55 Gag successfully co-precipitated in a specific manner with both Stau1 55 -flag and Stau1 ΔNt88 -FLAG ( Figure 5E, right panel) . These results show that, although Stau1 ΔNt88 is unable to stimulate Pr55 Gag multimerization, its interaction with Pr55 Gag was maintained. This result suggests that Stau1 association to Pr55 Gag is not sufficient to influence HIV-1 assembly and that Stau1 Nterminus contains a regulatory element that is important for its function during this process.
Stau1 ΔNt88 -HA 3 does not enhance the assembly of membrane-associated Pr55 Gag complexes
We previously showed that the Stau1-mediated enhancement of Pr55 Gag multimerization occurs in membrane compartments [51] . Therefore, to test whether Stau1 ΔNt88 -HA 3 reaches the membranes and whether the whole cell analysis described above masked an effect of Stau1 ΔNt88 -HA 3 on assembly, membrane-associated virus assembly was analyzed in the context of Stau1 ΔNt88 -HA 3 or Stau1 55 -HA 3 over-expression. Cytoplasmic extracts from transfected 293T cells were analyzed by the membrane flotation assay ( Figure 6A ) [51] . This assay allows the separation of membrane-associated complexes (fraction 2; M) from the cytosolic ones (fractions 7, 8 and 9; Cy). First, Western blot analysis indicated that Stau1 ΔNt88 -HA 3 was both over-expressed and present in membranes at the same levels as Stau1 55 -HA 3 (data not shown). As previously described [51] , Pr55 Gag /Pr55 Gag BRET was readily detected in the membrane fraction (BRET ratio of 0.33) but not in the cytosolic fractions consistent with the fact that HIV-1 assembly occurs on cellular membranes (Figure 6B) [10, 61, 62] . Moreover, as reported before, Stau1 55 -HA 3 over-expression led to an increase of 1.6-fold in the Pr55 Gag /Pr55 Gag BRET ratio in the membrane fraction but
The N-terminus of Stau1 is required for the modulation of Pr55 Gag multimerization in live cells not in the cytosolic fraction [51] . In contrast, there was little change in the ability of Pr55 Gag to multimerize in the membrane fraction when the mutant Stau1 ΔNt88 -HA 3 was over-expressed.
The inability of Stau1 ΔNt88 -HA 3 to modulate Pr55 Gag multimerization was then tested in the context of provirusdriven immature HIV-1 production. We had previously shown that Stau1-mediated increase in Pr55 Gag multimerization correlated with a partial resistance to mild detergent treatment of membrane-associated Pr55 Gag complexes [51] . Stau1 expressors and the protease-defective provirus HxBRU PR-were cotransfected in 293T cells. Forty hours post-transfection, membrane flotation assays on cytoplasmic extracts were performed and fractions containing membrane-associated complexes were collected. The resulting complexes were then subjected to ultracentrifugation at 100,000 × g for 1 hour ( Figure 6C ). In this assay, insoluble or high-density complexes are found in the pellet (P100) whereas proteins that are soluble or components of small complexes are retained in the supernatant (S100). Resulting P100 and S100 fractions were analyzed by Western blot. As previously shown [51] , Pr55 Gag as well as the membrane marker, sodium potassium (Na-K) ATPase, were primarily found in the P100 fraction because Pr55 Gag was membrane-associated (data not shown). This was observed whether Stau1 proteins were over-expressed or not (data not shown). To separate Pr55 Gag complexes from membranes, membranes were solubilized with 0.5% Triton-X100. These experiments were done at room temperature to also solubilize lipid rafts and other membrane compartments that are detergent-resistant at 4°C. As reported before, membrane solubilization prior to S100/P100 fractionation resulted in a complete shift of Pr55 Gag complexes and Na-K ATPase into the S100 fraction ( Figure 6D ) [51] . Stau1 55 -HA 3 overexpression led to a partial resistance of 33% of Pr55 Gag complexes to Triton-X100 treatment, likely as a consequence of enhanced Pr55 Gag multimerization ( Figure 6D ). In contrast, Stau1 ΔNt88 -HA 3 , as well as Stau1 F135A -HA 3 used as control [51, 52] failed to increase the density of Pr55 Gag complexes. Altogether, these results support the conclusion that the N-terminus of Stau1 is required for Stau1mediated increase of Pr55 Gag assembly during HIV-1 assembly.
Amino acids 26 to 37 of Stau1 55 are important for its function in Pr55 Gag multimerization
To more precisely map the functional determinant within the N-terminal region that is involved in the regulation of Pr55 Gag multimerization, we generated two additional deletion mutants, Stau1 ΔNt25 -HA 3 and Stau1 ΔNt37 -HA 3 and confirmed their expression ( Figure 7A ). Using the Pr55 Gag /Pr55 Gag BRET assay in live 293T cells, Stau1 ΔNt25 -HA 3 enhanced the BRET ratio like wild type Stau1 55 -HA 3
suggesting that the first 25 amino acids are not required for this function ( Figure 7B ). In contrast, Stau1 ΔNt37 -HA 3 did not significantly enhance the BRET ratio and generated a BRET curve similar to that obtained with Stau1 ΔNt88 -HA 3 . Expression of increasing amounts of Stau1 55 -HA 3 or Stau1 ΔNt25 -HA 3 (Figure 7C ) led to a comparable increases of Pr55 Gag /Pr55 Gag BRET ratio up to 2.16-2.34-fold ( Figure 7D) . In contrast, expression of Stau1 ΔNt37 -HA 3 or Stau1 ΔNt88 -HA 3 had no effect on Pr55 Gag /Pr55 Gag BRET ratio when their expression is relatively low. However, when highly expressed, they slightly enhanced the BRET ratio by 1.34-1.47-fold. These results suggest that the sequence located between amino acids 26 and 37 is important for Stau1-mediated enhancement of Pr55 Gag multimerization and show that Stau1 acts on Pr55 Gag multimerization in a dose-dependent manner.
Effect of Stau1 N-terminal mutants on VLP production
We already showed that Stau1 over-expression, likely as a consequence of its role in multimerization, also increases VLP release from the cell [51] . Therefore, considering the inability of Stau1 ΔNt88 to influence Pr55 Gag multimerization (Figure 4 ), we suspected that over-expression of Stau1 ΔNt88 would not stimulate VLP production. To test this idea, Pr55 Gag and either Stau1 55 -HA 3 or Stau1 ΔNt88 -HA 3 were co-expressed in 293T cells. Twenty-four hours post-transfection, the levels of VLP release were analyzed by Western blotting ( Figure 8A ). As expected, a 2-fold increase in the expression of Stau1 55 -HA 3 as compared to endogenous Stau1 resulted in a 2.5-fold increase in VLP release while the cellular level of Pr55 Gag remained unchanged. In contrast, over-expression of Stau1 ΔNt88 -HA 3 did not stimulate VLP production. To confirm these results, dose-response assays were performed. Constant amounts of Pr55 Gag were co-expressed with increasing amounts of either Stau1 55 -HA 3 or Stau1 ΔNt88 -HA 3 ( Figure  8B ). As previously shown [51] , Stau1 55 -HA 3 over-expression stimulated VLP production in a dose-dependent manner up to 10-fold with no significant change in the intracellular level of Pr55 Gag . In contrast, Stau1 ΔNt88 -HA over-expression did not lead to a significant increase of VLP release, except at high expression levels ( Figure 8C ). However, the stimulation of VLP production by Stau1 ΔNt88 -HA 3 was always less than that produced by Stau1 55 -HA 3 , when expressed at the same level. Analyses of VLP production in the presence of Stau1 ΔNt25 -HA and Stau1 ΔNt37 -HA indicated that, whereas Stau1 ΔNt25 -HA enhanced VLP release, Stau1 ΔNt37 -HA did not ( Figure 8D ) consistent with the conclusion that Stau1 molecular determinant for enhanced Pr55 Gag multimerization is carried by amino acids 26 to 37.
Discussion
We previously reported that Stau1 participates in HIV-1 assembly by influencing Pr55 Gag multimerization [51] .
Identification of the N-terminal region of Stau1 55 as a regulatory sequence for HIV-1 assembly However, very little is known about the molecular mechanisms underlying this process. In this report, we show that, in addition to Pr55 Gag -binding via its dsRBD3 [51, 52] , Stau1's effect on Pr55 Gag multimerization depends on amino acids located within its N-terminus. Moreover, we show important contributions from both NC zinc fingers for the Stau1/Pr55 Gag interaction suggesting that Stau1 influences processes that depend on these NC sub-domains.
HIV-1 Gag mutants whose zinc fingers were disrupted, failed to interact with Stau1 as seen in BRET and coimmunoprecipitation assays (Figure 2 ). This suggests that Stau1 directly makes contact with these structures although we cannot rule out the possibility that these combined mutations affect the structure of other subdomains of NC and potentially a Stau1-binding motif. Interestingly, viruses that harbour these mutations do not encapsidate Stau1 [53] . Although this phenotype could be attributed to the loss of HIV-1 genomic RNA packaging and to Stau1 RNA-binding activity, this strongly suggests that Stau1 encapsidation into HIV-1 may be achieved by the formation of a Stau1-Gag-RNA ternary complex where Stau1 interactions with both Pr55 Gag and genomic RNA contribute to this process [51, 52] .
NC zinc fingers are known to play important roles during several steps of the HIV-1 replication cycle such as genomic RNA packaging and reverse transcription [27] [28] [29] 63 ]. In addition, they have been shown to be involved in Pr55 Gag assembly [5, 6, 29, 30, 46, 64] . Our results with the BRET assay that monitors direct interaction between wild type and mutated Pr55 Gag proteins are consistent with these results. Whereas some studies reported dramatic defects in assembly and particle production only when both zinc fingers were disrupted [29, 46] , other showed that mutations in either of the NC zinc fingers (especially the C-terminal one) impaired HIV-1 assembly [30] . It is possible that the loss of one zinc finger can be compensated by the intact one and would explain why, in certain studies, single mutation within these motifs have no major effects on HIV-1 assembly. Interestingly, mutations in both zinc fingers are required for a complete loss of interaction between Stau1 and Pr55 Gag , mutation in one zinc finger causing only a partial reduction. Therefore, through its interaction with the zinc fingers, Stau1 most likely influences steps of assembly that are controlled by the NC zinc fingers. In addition, we do not exclude the possibility that Stau1 also participates in other steps of HIV-1 life cycle that depend on NC [65] .
Although both Stau1 and the Gag-NC zinc fingers are engaged in specific interactions with the genomic HIV-1 RNA, we do not have any evidence that Stau1 interacts with NC via the genomic RNA since the Stau1-Pr55 Gag association was shown to be resistant to RNase treatment [52] . Moreover, although the C15/49S NC mutant retains its ability to bind RNA nonspecifically through its basic amino acids [24] [25] [26] , this mutant is unable to recruit Stau1 supporting the idea that Stau1/Gag-NC interaction is not bridged by RNA. Nevertheless, it is possible that Stau1-Gag-NC interactions favour recruitment of the genomic RNA and its subsequent trafficking and encapsidation. Indeed, mutating the conserved CCHC residues of the NC zinc fingers drastically impairs genomic RNA packaging in newly formed virions and that of Stau1 [53] . We previously showed that Stau1 association with HIV-1 genomic RNA is required for its subsequent encapsidation into the viral particle [53] , our results now suggest that Stau1/Gag-NC interaction is also a critical determinant for this process. In addition, whether Stau1 interacts first with NC or with the genomic RNA to recruit the other partner or independently interacts with each of them through different pathways during HIV-1 assembly and RNA packaging processes is still unknown. The identification of a Stau1 mutant that retains its ability to associate with genomic RNA but is defective for Pr55 Gag binding will help answer these questions.
We identified the first 88 amino acids of Stau1 as a regulatory motif of its activity during HIV-1 assembly. Indeed, whereas Stau1 ΔNt88 -HA 3 mutant is still able to interact with Pr55 Gag , it fails to enhance Pr55 Gag multimerization as seen by BRET, fractionation and VLP release assays. These results strongly suggest that Stau1-binding to Pr55 Gag is not sufficient to influence HIV-1 assembly. They eliminate the possibility that the observed increase in the Pr55 Gag /Pr55 Gag BRET ratio upon Stau1 55 -HA 3 overexpression was the result of non-specific changes in the proximity of Rluc and YFP tags due to Stau1 recruitment towards assembly complexes. Similarly, the possibility of major overall structural changes in Stau1 ΔNt88 -HA 3 can be ruled out. Indeed, the Stau1 ΔNt88 -HA 3 mutant retains its capacity to homo-dimerize, to enhance translation of repressed mRNAs, to bind ribosomes and to associate with membranes (unpublished data). Consequently, this sequence probably confers highly specific functions to Stau1 that are advantageous for HIV-1 assembly. It will be interesting to study Stau1 ΔNt88 encapsidation into HIV-1 as a means to determine whether the Stau1-mediated enhancement of Pr55 Gag multimerization is a prerequisite for its intraviral packaging or whether it relies on its association with HIV-1 genomic RNA and on the control of RNA selection for encapsidation [53] .
How does this region control Stau1 activity? It is likely that Stau1, in conjunction with its Pr55 Gag -binding activity, attracts host factors to Pr55 Gag complexes that are crucial for assembly. NC-associated proteins that are also important for the transition between specific Pr55 Gag assembly intermediates such as ABCE1 [44, 45, 47] are good candidates. Although ABCE1/Pr55 Gag interaction depends on NC basic amino acids [46] , the disruption of both NC zinc fingers resulted in the loss of ABCE1/ Pr55 Gag association by 80% [46] . Thus, it will be important to elucidate the functional relationship between Stau1 and NC-associated proteins to determine if their respective acquisition by assembly intermediates and functions during HIV-1 assembly are simultaneous or sequential.
Within the first 88 N-terminal amino acids of Stau1, a region of 12 amino acids (M 26 RGGAYPPRYFY 37 ) controls Stau1 functions in regard to Pr55 Gag assembly. Post-translational modifications are very common among RNAbinding proteins such as hnRNPs and RNA helicase A and are known to regulate their cellular proteome, function and localization [66] [67] [68] [69] . It is then conceivable that posttranslational modification of Stau1's N-terminal region controls the recruitment of protein partners and/or modulates Stau1 function during HIV-1 assembly. Alternatively, the N-terminal sequence may recruit ubiquitin ligase through two potential ESCRT targeting domains (PPRY and YPFPVPPL) [50] . In most retroviruses (except HIV-1), the PPXY motif in Gag recruits a ubiquitin ligase and is required for virus budding and release [50, 70, 71] . Resulting ubiquitination allows targeting of the PPXYcontaining protein to the ESCRT machinery located to the multivesicular bodies. Similarly, the YPX(n)L domain that is also present in some retroviruses (including HIV-1) recruits the AIP1/ALIX protein that also targets the cargo to the ESCRT [50, 72, 73] . Although Stau1 ΔNt88 -HA 3 associates with membrane as efficiently as Stau1 55 -HA 3 (data not shown), it is conceivable that these signals control the localization of Stau1 to specific membrane compartments to support HIV-1 assembly. Interestingly, Popov et al. recently showed that AIP1/ALIX, through its Bro1 domain, is able to bind the NC domain of Pr55 Gag in addition to p6 [64] . Strikingly, this interaction requires the integrity of both zinc fingers and is RNA-independent, as observed for Stau1/Pr55 Gag association. When overexpressed, AIP1/ALIX rescues the release defect of late domain-mutated HIV-1. Although AIP-1/ALIX overexpression has no effect on wild type HIV-1 release [74] , in contrast to Stau1 [51] , it is possible that Stau1 and AIP-1/ALIX, through their simultaneous or sequential association with the NC zinc fingers, cooperate during HIV-1 assembly. The putative interplay between AIP1/ALIX, ESCRTs and Stau1 during both wild type and L-domainmutated virus assembly will be very interesting to explore in future studies.
Finally, our work highlights the modular nature of the Stau1 protein in the following ways. The double-stranded RNA binding domain (dsRBD3) interacts with Pr55 Gag [52] whereas the N-terminus controls its activity during HIV-1 assembly. This is supported by the fact that Stau1 Δ88 -HA 3 still associates with HIV-1 Gag ( Figure 5 ) but fails to enhance its multimerization (Figures 4, 6, 8) . Strikingly, Drosophila Stau1 orthologue, dStau, has also been shown to function as a modular protein [75] . The third dsRBD of dStau for example is involved in dStau association to oskar RNA whereas the second dsRBD is important for the microtubule-dependent transport of the mRNP and the fifth dsRBD is involved in the derepression of oscar mRNA translation, once localized [75] .
Conclusion
In this study, we provide important new information about the determinants in both Stau1 and Pr55 Gag that impact on HIV-1 assembly.
